Ralliant Corporation ("Ralliant" or the "Company") today announced financial results for the first quarter of 2026. For the first quarter, revenue of $535 million was up 11% year-over-year and up 9% ...
As the human lifespan continues to increase worldwide, so is the number of people seeking solutions for age-related conditions. Nicotinamide mononucleotide (NMN) is one of the main precursors of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results